It criticised sloppy administration, a lack of staff training, inadequate insurance cover and a delay in appropriate counter treatment.
Damming, but not enough for the claimants’ solicitors, who branded the investigation a sham. Claimed the next day’s headlines: ‘Victims’ fury over elephant drug “whitewash”’ (Daily Mirror, 26 May); ‘Drug test review is “whitewash”’ (The Daily Telegraph, 26 May).
The investigation had been carried out by drug industry watchdog the MHRA, with inevitable questions over its impartiality. ‘Today’s report is inadequate and completely misses the point’ was an independent drug expert’s view (bbc.co.uk, 25 May).
With calls for an independent review, the effects of this trial will be felt by victims and industry for some time.
Analysis conducted by Echo Research from data supplied to PRWeek from NewsNow www.echoresearch.com www.newsnow.com